about
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachCD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer.Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemiaCD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma.CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and MetastasisMembranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients.Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomasDeletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.Focal adhesion kinase activity is required for actomyosin contractility-based invasion of cells into dense 3D matrices.CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24.CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation.CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2Ovarian cancer stem cells: a new target for cancer therapy.Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma.Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.
P2860
Q26849477-00DD050D-A96F-4339-85C7-D5A6FA733915Q33711342-C2B4B157-30C1-4530-9D82-A290ECD2B1BEQ34655592-4062F66A-E8C0-4C10-8640-6FF3C81E5A07Q35056301-C3275CB4-9808-48F2-897D-255C3781E7BBQ35292720-FD9E3B82-29D1-4406-93DC-0F501EF04FDAQ35783549-254EBFA4-D6F8-4003-84EF-8B15B2F4A86CQ35832582-13346045-80B0-46E5-A442-0BE077AFE7A9Q35844656-BEC7EA02-8D63-4DF9-AE45-1613371FD40EQ36378949-43947734-543A-4D61-B81B-74E4CD8F940AQ36775313-ADC5160E-B696-417C-AC73-F440891A9C14Q36811339-9849F7A6-2CFE-4025-9113-0CA3BE4D8EDEQ37644266-952BC296-D154-489B-897A-E6C8218C0A2BQ37688297-1E4FB72C-E007-4ED9-B4A4-99090B87FFE1Q38311444-00734F27-9D11-4333-A1BF-103F3F769A8BQ39044616-E5079C20-D3CE-4A8D-915D-48B1670A1DC9Q41856181-BC5C93FC-F410-46A3-9C84-0124DE592E85Q42092160-60BF0C06-0143-41FD-8D07-8A8FCF239C32Q46080553-088DDF17-3783-4A29-97DD-FACA7E1B1E5FQ51395620-F256F7D7-2DD5-4D36-9148-69E5268323CDQ53262282-69591A68-2406-42E3-A02B-6FB40F257CCE
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CD24 controls Src/STAT3 activity in human tumors.
@en
CD24 controls Src/STAT3 activity in human tumors.
@nl
type
label
CD24 controls Src/STAT3 activity in human tumors.
@en
CD24 controls Src/STAT3 activity in human tumors.
@nl
prefLabel
CD24 controls Src/STAT3 activity in human tumors.
@en
CD24 controls Src/STAT3 activity in human tumors.
@nl
P2093
P2860
P1476
CD24 controls Src/STAT3 activity in human tumors
@en
P2093
Alexei V Salnikov
Claudia Perne
Gerhard Moldenhauer
Mina Fogel
Natalie Erbe-Hofmann
Niko P Bretz
Peter Altevogt
Sascha Keller
Thomas Schlange
Xiaoli Wang
P2860
P2888
P304
P356
10.1007/S00018-012-1055-9
P577
2012-07-04T00:00:00Z